![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/00 | (2006.01) |
A61K 9/0014 | (2013.01) | ||
A61K 9/06 | (2006.01) | ||
A61K 47/02 | (2013.01) | ||
A61K 9/12 | (2006.01) | ||
A61K 9/06 | (2013.01) | ||
A61K 38/22 | (2006.01) | ||
A61K 38/2292 | (2013.01) | ||
A61K 47/18 | (2006.01) | ||
A61K 47/38 | (2013.01) | ||
A61K 47/26 | (2006.01) | ||
A61K 47/32 | (2013.01) | ||
A61K 47/10 | (2006.01) | ||
A61K 47/32 | (2006.01) | ||
A61K 47/38 | (2006.01) | ||
A61K 47/02 | (2006.01) |
(11) | Number of the document | 3590497 |
(13) | Kind of document | T |
(96) | European patent application number | 17899160.0 |
Date of filing the European patent application | 2017-08-04 | |
(97) | Date of publication of the European application | 2020-01-08 |
(45) | Date of publication and mention of the grant of the patent | 2023-03-29 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/KR2017/008442 |
Date | 2017-08-04 |
(87) | Number | WO 2018/159906 |
Date | 2018-09-07 |
(30) | Number | Date | Country code |
20170027706 | 2017-03-03 | KR |
(72) |
CHOI, Jun Won , KR
KIM, Kyoungsun , KR
LEE, Si Young , KR
UM, Tae Heum , KR
|
(73) |
HLB Therapeutics Co., Ltd. ,
22F, 248 Jeongjail-ro
Bundang-gu, Seongnam-si, Gyeonggi-do 13554,
KR
|
(54) | STABILIZED EXTERNAL USE AGENT COMPRISING THYMOSIN BETA-4 AS EFFECTIVE INGREDIENT |
STABILIZED EXTERNAL USE AGENT COMPRISING THYMOSIN BETA-4 AS EFFECTIVE INGREDIENT |